Holen Sie sich die Stockscreener-App
5.56
3.30%
-0.19
Handel nachbörslich:
5.47
-0.09
-1.62%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SLDB?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$5.75
Offen:
$5.76
24-Stunden-Volumen:
659.57K
Relative Volume:
0.47
Marktkapitalisierung:
$432.95M
Einnahmen:
$14.79M
Nettoeinkommen (Verlust:
$-102.44M
KGV:
-1.8289
EPS:
-3.04
Netto-Cashflow:
$-91.73M
1W Leistung:
-1.07%
1M Leistung:
-18.48%
6M Leistung:
+4.71%
1J Leistung:
-34.59%
1-Tages-Spanne:
$5.41
$5.76
1-Wochen-Bereich:
$5.34
$5.77
52-Wochen-Spanne:
$2.41
$8.745
Solid Biosciences Inc Stock (SLDB) Company Profile
Firmenname
Solid Biosciences Inc
Sektor
Branche
Telefon
617-337-4680
Adresse
500 RUTHERFORD AVENUE, CHARLESTOWN, MA
Vergleichen Sie SLDB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SLDB
Solid Biosciences Inc
|
5.56 | 422.83M | 14.79M | -102.44M | -91.73M | -3.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Solid Biosciences Inc Stock (SLDB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-26 | Eingeleitet | Citigroup | Buy |
| 2025-01-08 | Eingeleitet | Truist | Buy |
| 2024-12-13 | Eingeleitet | Wedbush | Outperform |
| 2024-12-10 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-07-15 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-06-24 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-05-31 | Fortgesetzt | Piper Sandler | Overweight |
| 2024-03-28 | Eingeleitet | William Blair | Outperform |
| 2024-03-15 | Eingeleitet | Citigroup | Buy |
| 2024-03-14 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-12-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-07-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-05-27 | Eingeleitet | Jefferies | Buy |
| 2021-03-16 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2021-03-09 | Eingeleitet | Barclays | Overweight |
| 2021-01-08 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2020-07-28 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-05-07 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-10-11 | Eingeleitet | Evercore ISI | Outperform |
| 2019-08-29 | Herabstufung | Citigroup | Neutral → Sell |
| 2019-08-19 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2019-08-16 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2019-05-14 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2019-05-14 | Herabstufung | Goldman | Neutral → Sell |
| 2019-02-08 | Hochstufung | Citigroup | Sell → Neutral |
| 2019-02-08 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2018-11-06 | Eingeleitet | Citigroup | Sell |
| 2018-09-06 | Eingeleitet | Credit Suisse | Neutral |
Alle ansehen
Solid Biosciences Inc Aktie (SLDB) Neueste Nachrichten
Using economic indicators to assess Solid Biosciences Inc. potentialJuly 2025 Update & AI Optimized Trading Strategy Guides - Newser
Solid Biosciences Inc. stock trendline breakdownShort Setup & Weekly Chart Analysis and Guides - Newser
Solid Biosciences Inc. stock trend forecastJuly 2025 EndofMonth & Fast Entry High Yield Stock Tips - Newser
Will Solid Biosciences Inc. rebound enough to break evenShare Buyback & Consistent Growth Equity Picks - Newser
Smart tools for monitoring Solid Biosciences Inc.’s price actionEarnings Recap Report & Low Drawdown Investment Ideas - Newser
Has Solid Biosciences Inc. formed a bullish divergence2025 Winners & Losers & Weekly Consistent Profit Watchlists - Newser
How sentiment analysis helps forecast Solid Biosciences Inc.July 2025 Action & Weekly Return Optimization Alerts - Newser
Is Solid Biosciences Inc. meeting your algorithmic filter criteria2025 EndofYear Setup & Technical Confirmation Alerts - Newser
Live market analysis of Solid Biosciences Inc.Treasury Yields & Daily Profit Focused Screening - Newser
What’s Solid Biosciences Inc.’s historical returnQuarterly Trade Review & Risk Managed Investment Strategies - khodrobank.com
Can swing trading help recover from Solid Biosciences Inc. lossesBear Alert & Safe Capital Growth Stock Tips - Newser
Technical analysis overview for Solid Biosciences Inc. stockGold Moves & Risk Controlled Stock Alerts - Newser
Is Solid Biosciences Inc. stock a value trap2025 Macro Impact & AI Powered Market Entry Strategies - khodrobank.com
What the charts say about Solid Biosciences Inc. todayMarket Sentiment Review & Weekly High Return Stock Forecasts - Newser
Risk On: What’s the MACD signal for Solid Biosciences Inc.Trade Exit Summary & Community Consensus Stock Picks - khodrobank.com
Will Solid Biosciences Inc. bounce back from current supportTrend Reversal & Capital Protection Trade Alerts - Newser
News impact scoring models applied to Solid Biosciences Inc.July 2025 Decliners & Verified Momentum Stock Ideas - Newser
Real time breakdown of Solid Biosciences Inc. stock performanceMarket Performance Report & Free Long-Term Investment Growth Plans - Newser
Applying Wyckoff theory to Solid Biosciences Inc. stockStop Loss & Free Weekly Watchlist of Top Performers - Newser
What moving averages say about Solid Biosciences Inc.New Guidance & Daily Price Action Insights - Newser
Solid Biosciences Inc. stock retracement – recovery analysisEarnings Growth Report & Stepwise Swing Trade Plans - Newser
Is Solid Biosciences Inc. stock entering bullish territory2025 Macro Impact & Free Accurate Trade Setup Notifications - Newser
How moving averages guide Solid Biosciences Inc. tradingJuly 2025 Recap & Daily Price Action Insights - Newser
Analyzing Solid Biosciences Inc. with multi timeframe chartsAnalyst Downgrade & Fast Entry High Yield Stock Tips - Newser
Custom watchlist performance reports with Solid Biosciences Inc.Market Sentiment Summary & Free Weekly Chart Analysis and Trade Guides - Newser
How is Solid Biosciences Inc. managing supply chain issuesWeekly Earnings Recap & Growth Oriented Trading Recommendations - khodrobank.com
Trend Report: What is Solid Biosciences Inc.’s TAM (Total Addressable Market)July 2025 Highlights & High Accuracy Investment Signals - khodrobank.com
Will Solid Biosciences Inc. benefit from government policyJuly 2025 Recap & Fast Moving Stock Trade Plans - خودرو بانک
How to use Fibonacci retracement on Solid Biosciences Inc.Market Weekly Review & Fast Exit/Entry Strategy Plans - Newser
Can Solid Biosciences Inc. stock outperform in a bear marketJuly 2025 Highlights & Daily Risk Controlled Trade Plans - khodrobank.com
Solid Biosciences Inc. stock prediction for this weekBuy Signal & Safe Capital Preservation Plans - Newser
What is Solid Biosciences Inc.’s valuation compared to sectorMarket Sentiment Report & Real-Time Buy Zone Alerts - khodrobank.com
Using R and stats models for Solid Biosciences Inc. forecastingPortfolio Update Report & AI Enhanced Execution Alerts - Newser
Is Solid Biosciences Inc. stock poised for growthPortfolio Risk Summary & Technical Pattern Alert System - Newser
Will Solid Biosciences Inc. stock benefit from interest rate changesRecession Risk & Real-Time Market Trend Scan - Newser
Will a bounce in Solid Biosciences Inc. offer an exit2025 Dividend Review & Risk Managed Investment Strategies - Newser
Finanzdaten der Solid Biosciences Inc-Aktie (SLDB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Solid Biosciences Inc-Aktie (SLDB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Bain Capital Life Sciences Inv | 10% Owner |
Feb 19 '25 |
Buy |
4.03 |
1,000,000 |
4,030,000 |
5,034,582 |
| PERCEPTIVE ADVISORS LLC | Director |
Feb 19 '25 |
Buy |
4.03 |
5,000,000 |
20,150,000 |
11,833,539 |
| Adage Capital Management, L.P. | 10% Owner |
Feb 18 '25 |
Buy |
7.56 |
252,545 |
1,909,240 |
4,248,084 |
| Hanrahan Jessie | Chief Regulatory Officer |
Feb 14 '25 |
Sale |
3.96 |
3,079 |
12,193 |
19,281 |
| Brooks Gabriel | Chief Medical Officer |
Feb 14 '25 |
Sale |
3.96 |
3,256 |
12,894 |
22,812 |
| Tan Kevin | CFO & Treasurer |
Feb 14 '25 |
Sale |
3.96 |
3,164 |
12,529 |
32,250 |
| Howton David T | Chief Operating Officer |
Feb 14 '25 |
Sale |
3.96 |
5,561 |
22,022 |
24,789 |
| Herzich Paul | Chief Technology Officer |
Feb 14 '25 |
Sale |
3.96 |
2,688 |
10,644 |
18,388 |
| Cumbo Alexander | President and CEO |
Feb 14 '25 |
Sale |
3.96 |
11,365 |
45,005 |
60,717 |
| Ganot Ilan | Director |
Feb 14 '25 |
Sale |
3.96 |
1,711 |
6,776 |
14,839 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):